Who owns Proqr Thrapeutics N V shs euro?
- Ticker: PRQR
- CUSIP Number: n71542109
Tip: Access positions for across all investors
Analyze quarterly positions in Proqr Thrapeutics N V shs euro with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Proqr Thrapeutics N V shs euro stock
Who bought or sold Proqr Thrapeutics N V shs euro this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Privium Fund Management B.V. | 5.3M | $12M | 0% | Mar 2024 |
|
| Adage Capital Partners GP | 3.6M | $8.3M | 0% | Mar 2024 |
|
| EcoR1 Capital | 2.9M | $6.6M | -3% | Mar 2024 |
|
| M28 Capital Management | 1.9M | $3.8M | 0% | Dec 2023 |
|
| DAFNA Capital Management | 906k | $2.1M | -4% | Mar 2024 |
|
| Ikarian Capital | 484k | $1.1M | 2% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 385k | $882k | 0% | Mar 2024 |
|
| Millennium Management | 329k | $747k | -27% | Mar 2024 |
|
| Monaco Asset Management SAM | 313k | $710k | -17% | Mar 2024 |
|
| Two Sigma Advisers | 162k | $371k | -4% | Mar 2024 |
|
| Susquehanna International | 157k | $356k | 286% | Mar 2024 |
|
| Squarepoint Ops | 153k | $346k | 19% | Mar 2024 |
|
| Franklin Street Advisors | 150k | $343k | 0% | Mar 2024 |
|
| Bank of America Corporation | 110k | $252k | 41% | Mar 2024 |
|
| Boothbay Fund Management | 107k | $244k | 11% | Mar 2024 |
|
| Citadel Advisors | 94k | $213k | -9% | Mar 2024 |
|
| Two Sigma Investments | 79k | $181k | -21% | Mar 2024 |
|
| Morgan Stanley | 68k | $155k | -80% | Mar 2024 |
|
| Geode Capital Management | 47k | $106k | 29% | Mar 2024 |
|
| Resources Investment Advisors | 45k | $103k | 130% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 35k | $80k | 120% | Mar 2024 |
|
| RFG Advisory | 32k | $73k | 100% | Mar 2024 |
|
| Bank Of Montreal | 30k | $73k | 0% | Mar 2024 |
|
| Virtu Financial | 26k | $59k | -26% | Mar 2024 |
|
| Acadian Asset Management | 25k | $56k | 100% | Mar 2024 |
|
| Two Sigma Securities | 24k | $54k | 123% | Mar 2024 |
|
| JustInvest | 21k | $49k | 0% | Mar 2024 |
|
| Mariner Wealth Advisors | 18k | $42k | 0% | Mar 2024 |
|
| Northern Trust | 17k | $40k | 0% | Mar 2024 |
|
| Simplex Trading | 14k | $30k | 655% | Mar 2024 |
|
| Advisor Group Holdings | 13k | $29k | 0% | Mar 2024 |
|
| Occudo Quantitative Strategies | 12k | $28k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 11k | $25k | 0% | Mar 2024 |
|
| Csenge Advisory Group | 10k | $23k | 0% | Mar 2024 |
|
| Vontobel Holding | 10k | $23k | 0% | Mar 2024 |
|
| Branch Banking & Trust Company | 10k | $23k | 0% | Mar 2024 |
|
| Kestra Advisory Services | 10k | $20k | 0% | Dec 2023 |
|
| Group One Trading | 9.7k | $22k | -1% | Mar 2024 |
|
| Lazard Asset Management | 5.9k | $0 | -6% | Dec 2023 |
|
| UBS Group | 5.0k | $11k | 27% | Mar 2024 |
|
| Cutler | 4.2k | $9.0k | -9% | Mar 2024 |
|
| BlackRock | 3.9k | $9.0k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 1.5k | $3.4k | -18% | Mar 2024 |
|
| PFS Partners | 1.0k | $2.3k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 200.00 | $0 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 33.00 | $74.999100 | 0% | Mar 2024 |
|
Who sold out of Proqr Thrapeutics N V shs euro?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Dec 2023 | 10k | $20k |
| Flaharty Asset Management | Sep 2023 | 2.0k | $2.6k |